¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"somatic mutation theory"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • frameshift mutation
    ƲÀ̵¿µ¹¿¬º¯ÀÌ
  • genetic mutation
    À¯Àüµ¹¿¬º¯ÀÌ
  • genomic mutation
    À¯Àüüµ¹¿¬º¯ÀÌ
  • induced mutation
    À¯¹ßµ¹¿¬º¯ÀÌ
  • loss-of-function mutation
    ±â´É¼Ò½Çµ¹¿¬º¯ÀÌ
  • missense mutation
    °ú¿Àµ¹¿¬º¯ÀÌ, ¹Ì½º¼¾½ºµ¹¿¬º¯ÀÌ
  • mutation
    µ¹¿¬º¯ÀÌ
  • mutation genetics
    º¯ÀÌÀ¯ÀüÇÐ
  • mutation rate
    µ¹¿¬º¯ÀÌÀ²
  • natural mutation
    ÀÚ¿¬µ¹¿¬º¯ÀÌ
  • nonsense mutation
    ¹«Àǹ̵¹¿¬º¯ÀÌ, ³Í¼¾½ºµ¹¿¬º¯ÀÌ
  • plaque morphology mutation
    ÆÇÇüŵ¹¿¬º¯ÀÌ, ÇöóÅ©Çüŵ¹¿¬º¯ÀÌ
  • point mutation
    Á¡µ¹¿¬º¯ÀÌ
  • polar mutation
    ±Ø¼ºµ¹¿¬º¯ÀÌ
  • population mutation
    Áý´Üµ¹¿¬º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • plaque morphology mutation
    (¢¡plaque-type mutation) ÇöóÅ©Çüµ¹¿¬º¯ÀÌ
  • plaque-type mutation
    ÇöóÅ©Çüµ¹¿¬º¯ÀÌ
  • point mutation
    Á¡µ¹¿¬º¯ÀÌ
  • polar mutation
    ±Ø¼ºµ¹¿¬º¯ÀÌ
  • population mutation
    Áý´Ü±ºµ¹¿¬º¯ÀÌ
  • reading frame mutation
    ÇØµ¶Æ²µ¹¿¬º¯ÀÌ
  • recessive mutation
    ¿­¼ºµ¹¿¬º¯ÀÌ
  • reverse mutation
    ¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
  • reversible mutation
    µÇÁý±âµ¹¿¬º¯ÀÌ, °¡¿ªµ¹¿¬º¯ÀÌ
  • spontaneous mutation
    ÀÚ¿¬µ¹¿¬º¯ÀÌ
  • suppression mutation
    ¾ïÁ¦µ¹¿¬º¯ÀÌ
  • temperature-sensitive mutation
    ¿Âµµ¹Î°¨µ¹¿¬º¯ÀÌ
  • voice mutation
    º¯¼º
  • alternation theory
    ±³¹ø¼³
  • backward failure theory
    ÈĹæÀå¾Ö¼³
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • somatic system
    ü¼º°è.
  • somatic type
    ½ÅüÇü
  • somatic veins
    ¸öÅëÁ¤¸Æ
  • somatic(parietal) mesoderm
    º®ÂÊÁ߹迱
  • back mutation
    ¿ªº¯ÀÌ
  • chromosomal mutation
    ¿°»öü(µ¹¿¬)º¯ÀÌ.
  • cold-sensitive mutation
    ÇÑ·©°¨¼ö¼º µ¹¿¬º¯ÀÌ
  • complementation of virus mutation
    ¹ÙÀÌ·¯½ºº¯ÀÌ (Áõ½Ä)º¸¿Ï(¡­ñòãÖÜÍèÇ).
  • conditional lethal mutation
    Á¶°ÇÄ¡»ç µ¹¿¬º¯ÀÌ
  • conditional mutation
    Á¶°Çµ¹¿¬º¯ÀÌ
  • dominant mutation
    ¿ì¼º[µ¹¿¬]º¯ÀÌ
  • dominant mutation
    ¿ì¼º(µ¹¿¬)º¯ÀÌ(¡­ÔÍæ×ܨì¶).
  • drift mutation
    ¿¬¼Óº¯ÀÌ(ææáÙܨì¶).
  • frameshift mutation
    ÇØµ¶Æ² µ¹¿¬º¯ÀÌ, ÇÁ·¹ÀÓ½¬ÇÁÆ® µ¹¿¬º¯ÀÌ
  • frequency, mutation
    µ¹¿¬º¯À̺óµµ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • second-site mutation
    µÑ° ÀÚ¸® º¯ÀÌ(ܨì¶)
  • semilethal mutation
    ÁØÄ¡»ç º¯ÀÌ(ñÞöÈÞÝܨì¶)
  • sign mutation
    ½ÅÈ£º¯ÀÌ(ãáûÜܨì¶)
  • silent mutation
    ħ¹¬ º¯ÀÌ(öØÙùܨì¶)
  • single-site mutation
    ¿ÜÀÚ¸® º¯ÀÌ(ܨì¶)
  • spontaneous mutation
    "ÀÚ¿¬º¯ÀÌ(í»æÔܨì¶), ÀúÀý·Îº¯ÀÌ(ܨì¶)"
  • subvital mutation
    ¾ÆÄ¡¸í º¯ÀÌ(ä¬öÈ٤ܨì¶)
  • suppressor mutation
    ¾ï¾Ð(ÀÚ)º¯ÀÌ(åääâ(í­)ܨì¶)
  • transverse mutation
    ¿°±âº¯È¯º¯ÀÌ(ç¤ÐñܨüµÜ¨ì¶)
  • umber mutation
    ¾Ï¹ö º¯ÀÌ
  • unstable mutation
    ºÒ¾ÈÁ¤(ÝÕäÌïÒ) º¯ÀÌ(ܨì¶)
  • up promoter mutation
    ÇÁ·Î¸ðÅÍ Ç×Áø(ùñòä) º¯ÀÌ (ܨì¶)
  • visible mutation
    °¡½Ã º¯ÀÌ(ʦãÊܨì¶)
  • zero-point mutation
    ¿µÁ¡(ÖÃïÇ) º¯ÀÌ(ܨì¶)
  • accumulation theory
    ´©Àû·Ð (ÒéîÝÖå)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 4
SSI segmental sequential irradiation; shoulder subluxation inhibition; small-scale integration; Social S...
SSI 4,6 Somatic Symptom Index [of DIS]
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • alternation theory
    ±³¹ø¼³
  • apposition theory
    ºÎÂø¼³
  • biophysical theory
    »ý¹°¸®Çм³
  • Burnet's clonal selection theory
    ?
  • chemo-parasitic theory
    È­ÇÐ ¼¼±Õ¼³
    ¿ì½ÄÀÇ ¿øÀο¡ °üÇÏ¿© Miller°¡ ¼¼¿î Çм³. ¿ì½ÄÀÇ ¹ß»ýÀº Ä¡¾ÆÀÇ ÁÖü¸¦ ÀÌ·é ¼®È¸¿°ÀÇ Å»È¸À̰í, ±× ¿øÀÎÀÌ µÇ´Â »êÀº À½½Ä¹° Áß¿¡ Æ÷ÇԵǾî Àִ ź¼öÈ­¹°À» ±¸°­³»ÀÇ ¼¼±ÕÀÌ ¹ßÈ¿ÇϹǷΠÀÎÇØ¼­ »ý±â´Â À¯±â»êÀ̶ó´Â °¡¼³À» ¼¼¿ü´Ù. Miller´Â ¿ì½Ä Á¶Á÷À» È­ÇÐÀûÀ¸·Î ºÐ¼®ÇÏ°í ±×°Í¿¡ Æ÷ÇԵǾî ÀÖ´Â Ä®½·°ú À¯±âÁúÀÇ ¾çÀÌ ÀÌ»óÇÏ°Ô °¨¼ÒµÇ¾î ÀÖ´Â °ÍÀ» ¾Ë¾Ò´Ù. Áï ¿ì½Ä Ç¥ÃþºÎÀÇ ¿¬È­ »ó¾ÆÁúÀº Á¤»óÀÇ Ä¡Áú¿¡ ºñÇÏ¿© 92.5%ÀÇ Ä®½·°ú 39.4%ÀÇ À¯±âÁúÀÌ ¼Õ½ÇµÇ¾î ÀÖ°í ¿ì½Ä ½ÉºÎ¿¡¼­´Â 22.0%ÀÇ Ä®½· »ó½ÇÀ» ³ªÅ¸³Â´Ù. ±×·¯¹Ç·Î ±×´Â ½ÇÇèÀ» ÅëÇÏ¿© Ä¡¾Æ¿¡ À¯±â»ê°ú »§°¡·ç¸¦ ¼¯Àº °ÍÀ» ¾È¿¡ ºÙ¿© ³õÀº °á°ú, »ýÈ­ÇÐÀûÀ¸·Î ¿ì½Ä°ú ºñ½ÁÇÑ »óŰ¡ ÀϾ´Â °ÍÀ» ±ú´Ý°í, ¿ì½ÄÀÇ °æ¿ì´Â »êÀÌ Å« ÀÛ¿ëÀ» Çϸç, ±× À¯±â»êÀº »ó¾Æ¼¼°ü³»³ª Ä¡¾ÆÀÇ Ç¥¸é¿¡¼­ º¼ ¼ö ÀÖ´Â ´ÙÁ¾ ´Ù¾çÀÇ ¼¼±Õ¿¡ ÀÇÇØ¼­ À½½Ä¹° Àܻ翡 Æ÷ÇÔµÈ Åº¼öÈ­¹°ÀÇ ¹ßÈ¿¿¡ ÀÇÇÑ °ÍÀ̶ó°í »ý°¢ÇÏ¿´À¸³ª ±×´Â ±× ÁÖ¿ªÀ» ¸ÃÀº ¼¼±ÕÀÌ ¹«¾ùÀΰ¡´Â ¾ð¸íÇÏÁö ¾Ê¾Ò´Ù. ÀÌ È­ÇÐ ¼¼±Õ¼³Àº Èļ¼±îÁö °­ÇÑ ¿µÇâÀ» ¹ÌÄ¡°í ¿ì½ÄÀÇ ¼¼±ÕÇÐÀû ¿¬±¸ÀÇ ÁÖ·ù¸¦ ÀÌ·ç¾î ¿Ô´Ù.
  • clonal selection theory
    Ŭ·Ð ¼±Åü³
  • Combinational theory
    Á¶ÇÕ¼³
    Ç×ü ¹ßÇöÀÇ ´Ù¾ç¼ºÀ» ¼ø¿­ Á¶ÇÕ¿¡¼­ ±¸ÇÏ´Â Çм³.
  • contagium theory
    Àü¿°¼³, °¨¿°¼³
  • doublet theory
    ÀÌÁß±Ø ¼³
  • Ehrlich`s side chain theory
    ¿¡¸¦¸®È÷ÀÇ Ãø¼â¼³
    Ç×ü »ý»ê ±âÀü¿¡ ´ëÇÏ¿© Á¦¾ÈµÈ °¡¼³ÀÇ Çϳª. ¸ðµç ü ¼¼Æ÷ Ç¥¸é¿¡´Â Ãø¼â¶ó°í ÇÏ´Â ¼ö¿ëü°¡ ÀÖ°í, À̰Ϳ¡ ´ëÀÀÇÏ´Â Ç׿øÀÌ °áÇÕÇϸé Ȱ¼ºÈ­ µÇ°í, Ãø¼â°¡ °úÀ× »ý»êµÇ¾î Ç×ü·Î¼­ Ç÷·ù ¼Ó¿¡ ¹æÃâµÈ´Ù°í ÇÏ´Â »ý°¢. Ç×ü »ý»êÀÇ ¼±Åü³ÀÇ ÃÖÃÊÀÇ °ÍÀÌ´Ù.
  • epoigenetic theory
    Èļº¼³
  • error accumulation theory
    ¿ÀÂ÷ ´©Àû¼³
    ³ëÈ­ÀÇ ¿øÀÎÁõ.
  • evolution theory
    ÁøÈ­·Ð
  • fluid mosaic theory
    À¯µ¿ ¸ðÀÚÀÌÅ© ¼³
  • ionic theory
    À̿¼³
    Àü·ù´Â ÀÌ¿ÂÀ» ¿î¹ÝÇÏ´Â ¿ªÇÒ¸¸À» Çϸç, Àü·ù¿Í´Â °ü°è¾øÀÌ ÀüÇØÁú ¿ë¾×Àº Ç×»ó ÀÏÁ¤ÇÑ Àü¸®µµ·Î¼­ Àü¸®ÇÏ¿© ÀÖ´Ù´Â ¼³.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
private mutation A rare mutation found usually only in a single family or a small population. It is like a privately printed book.
(12 Dec 1998)
hereditary mutation A gene change that occurs in a germ cell (an egg or sperm) to become incorporated in every cell in the body. Hereditary mutations (also called germline mutations) play a role in cancer as, for example, the eye tumour retinoblastoma and wilms' tumour of the kidney.
(12 Dec 1998)
homeotic mutation <embryology, genetics> A mutation that causes an organism to develop a homologous body part or structure in place of the part or structure that should normally be there (for example, developing a hand in place of a foot).
(09 Oct 1997)
silent mutation Mutations that have no effect on phenotype because they do not affect the activity of the product of the gene, usually because of codon ambiguity.
(18 Nov 1997)
site specific mutation An alteration of the structure of a gene at a specific sequence, usually referring to experimentally produced changes in gene sequence.
(05 Mar 2000)
spontaneous mutation A mutation which occurs by itself without first being affected by a mutagen, for example during the process of DNA replication. Spontaneous mutations arise at a remarkably constant rate. The rate that spontaneous mutations arise has been used as an evolutionary clock to estimate how closely related two (or more) separate species are to each other.
(09 Oct 1997)
natural mutation A mutation which occurs by itself without first being affected by a mutagen, for example during the process of DNA replication. Spontaneous mutations arise at a remarkably constant rate. The rate that spontaneous mutations arise has been used as an evolutionary clock to estimate how closely related two (or more) separate species are to each other.
(09 Oct 1997)
neutral mutation A mutation that has no selective advantage or disadvantage. Considerable controversy surrounds the question of whether such mutations can exist.
(18 Nov 1997)
new mutation Redundant term for a heritable trait present in the offspring but in neither parent, i.e., not a pre-existing mutant form inherited.
(05 Mar 2000)
substitution mutation A mutation caused by a nucleotide base being replaced by a different one.
(09 Oct 1997)
nonsense mutation <molecular biology> A mutation that causes a polypeptide chain to be ended prematurely.
(13 Nov 1997)
null mutation Change in a gene that leads to nothing, for example to no enzyme or to a nonfunctioning enzyme.
(12 Dec 1998)
suppressor mutation <molecular biology> Mutation that alleviates the effect of a primary mutation at a different locus.
May be through almost any mechanism that can give a primary mutation, but perhaps the most interesting class are the amber and ochre supressors, where the anticodon of the tRNA is altered so that it mis reads the termination codon and inserts an amino acid, preventing premature termination of the peptide chain.
(18 Nov 1997)
deletion mutation <molecular biology> A mutation in which one or more (sequential) nucleotides is lost by the genome. If the number lost is not divisible by 3 and is in a coding region, the result is a frameshift mutation.
(18 Nov 1997)
down promoter mutation <molecular biology> A mutation (a change in base pair sequence) in a promoter region, this results in lower gene expression (less transcription of the gene occurs).
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á